1. MG Donna Barbisch, USA Director, CBRN Integration April 26, 2005

2. 2 "There is nothing more difficult to take in hand, more perilous to conduct, or more uncertain in its success, than to take the lead in the introduction of a new order of things." Machiavelli 1513

4. 4 Transforming New Team Focused on: –Defining Equities Across DoD –Streamlining Processes –Synchronizing Effort –Improving Efficiency –Optimizing Capability –Promoting Interoperability BOTTOM LINE: EFFECTIVE SOLUTIONS IN THE HANDS OF THE USER

5. 5 Chemical and Biological Defense Program DATSD(CBD)

6. 6 CBDP Major Players Dr. Dale Klein ATSD(NCB) Dr. Klaus Schafer DATSD(CBD) BG Steve Reeves JPEO-CBD Dr. Charles Galloway Director, JSTO Dr. Barry Fridling JRO-CBRND (Acting) Mr. Walter Hollis Joint T&E Executive Agent BG Stan Lillie Joint Combat Developer

7. 7 Sorting Fact From Fiction Defining the issues

8. 8 Prepared for What? September 11, 2001 Total dead/missing: 2,988 Potential target: 50,000 in building 2,819 dead314 missing 92 Flight 11 65 Flight 175 Potential target: 23,000 in building 125 dead; 64 aboard Flight 77 Flt 93: 44 dead AP Statistics: 1/4/2002

9. 9 Influenza 1918550,000 deaths in US Prepared for What?

11. 11 Prepared for What?

12. 12 San Francisco Earthquake April 06, 1906 More than 3000 deaths Prepared for What?

13. 13 Tokyo 1995 5,500 seek care Potential Target: 5 million riders daily 1,500 Physically ill 12 deaths Prepared for What?

14. 14 OKLAHOMA CITY BOMBING APRIL 19, 1995 Prepared for What?

15. 15 SARS Severe acute respiratory syndrome (SARS) confirmed in Singapore on Sep 10 2003 Totals: November - August 2003  8422 SARS worldwide  916 deaths  32 countries Canada launches $176 million public relations campaign to draw visitors back Prepared for What?

16. 16 Challenge Prevention Diagnostics Protection Industry Academia Genomics/Proteomics Other Government Research Testing/ Proofing Process Industry Bottleneck NIAID /NIH DoD/Military tech base Process Production Distribution Storage Capability BioShieldDoD Basic Research DHS/NBACC GLP GMP Phase 1 Safety trials Product Transition

17. Strategic Framework Anticipate the threat Deliver capabilities –Near Term –Mid Term –Long Term

18. 18 Approach Alignment of Life-cycle Cost and Testing (from S&T through Acquisition) Major T&E Investment Moving More into Experimentation & Rigorous Analysis

19. 19 Emphasis Significant Interagency Collaboration Align with President's Global War on Terror Increased Investment in Future Technologies Infrastructure Rebuild New Sensor Approaches Systems Biology Approach to Medical Countermeasures

20. 20 Integrating Capabilities Doctrine Organization Training Materiel Leader development Personnel Facilities Oversight – Coordination – Integration

21. 21 Conclusion Finish What we Started on Classic Threats –Legacy Products Need Investment to Eliminate the Threat Future Threats –New Thinking –Bold Approaches –Harnessing Data to Provide Information

22. 22 Life is full of wonderful opportunities temporarily disguised as overwhelmingly irresolvable problems